TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 2 | 6 | 14 | 23 | 24 | 0 | 14 |
| P | %wins | 50 | 50 | 100 | 100 | 50 | 70 | ||||
| S | %ret | 1 | 1 | 1 | -3 | 0 | 0 | 0 | 0 | 0 | -3 |
| S | %wins | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/24/17 17:30 | 7/24/17 | GNCA | Genocea Biosciences, Inc. | Health | BioPrd | Biological Products, (No Diag | Poole Jonathan | MA | O | CFO | M.d | 139 | 3.09 | 0 | 45 | 39 | D | ||||||||||||||||
7/24/17 17:30 | 7/24/17 | GNCA | Genocea Biosciences, Inc. | Health | BioPrd | Biological Products, (No Diag | Poole Jonathan | MA | O | CFO | S.d | -270 | 6.00 | 0 | -45 | -53 | 39 | D | |||||||||||||||
5/10/17 16:44 | 5/8/17 | GNCA | Genocea Biosciences, Inc. | Health | BioPrd | Biological Products, (No Diag | Poole Jonathan | MA | O | CFO | S | -40 | 6.51 | 2 | -6 | -14 | 39 | D | -33 | 58 | 86 | 36 | 10 | -11 | -3 | -5 | -3 | ||||||
11/9/16 17:32 | 11/7/16 | GNCA | Genocea Biosciences, Inc. | Health | BioPrd | Biological Products, (No Diag | Poole Jonathan | MA | O | CFO | P | 23 | 3.34 | 1 | 7 | 69 | 17 | D | -58 | -40 | -1 | -21 | -36 | -9 | 1 | 10 | 8 | 17 | 12 | 20 | 60 | ||
5/10/16 16:25 | 5/9/16 | GNCA | Genocea Biosciences, Inc. | Health | BioPrd | Biological Products, (No Diag | Poole Jonathan | MA | O | CFO | P | 16 | 3.88 | 3 | 4 | 95 | 8 | D | -79 | -58 | -35 | 48 | -1 | -27 | -15 | -4 | -4 | -6 | 16 | 26 | -13 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |